Abstract:In the recent decades, advances have been made in the studies of hepatocellular carcinoma (HCC). Based on the further understanding of etiological factors involved in HCC, prevention of HCC is possible. Using hepatitis B vaccination in newborn babies, interferon therapy to control viral hepatitis B and C and improve quality of drinking water, HCC incidence has decreased. A prospective randomized control screening trial has indicated that screening decreased HCC mortality. Currently a 1 cm HCC is not difficult to be detected based on the progress of tumor marker and medical imaging . Surgical resection remains to play a key role to improve HCC prognosis. Of the 415 HCC patients who survived more than 5 years, 95.4％ of them received either 1st stage or 2nd stage resection.The 5-year survival of 1106 patients with small HCC resection was up to 63.7％ .In a group or 109 patients who had initially unresectable HCC treated by palliative surgery other than resection, and received 2nd stage resection after shrinkage of tumor, the 5-year survival was up to 62.2％. Comparison of large series of liver transplantation and resection for HCC demonstrates that transplantation is only suitable for small HCC, not suitable for resection due to liver dysfunction. The treatment pattern of HCC has been changed from surgery to a combination of surgery, regional cancer therapies and their multimodality combination." Evidence based" is currently advocated in clinical research, unfortunately, very few effective drug for HCC has been confirmed. Recurrence and metastasis will be an important target to be studied in the 21 century.

How to Translate the Basic Research Results into Clinical Practice in Hepatocellular Carcinoma

Research Progress on Cancer-Associated Fibroblasts in Hepatocellular Carcinoma

Translational Medicine in Hepatocellular Carcinoma

Research Progress of MicoRNA in Molecular Targeting Treatment of Hepatocellular Carcinoma

Translational research on the treatment of HBV related end stage liver disease in China

Translational Research of the Relationship Between Rapamycin and Hepatocellular Carcinoma

Translational Medicine in Primary Liver Cancer

Advances in Clinical and Basic Research for Hepatocellular Carcinoma in China: a 2023 Review

Hepatobiliary Surgery in the Era of Translational Medicine

Clinical and Experimental Studies on Recurrence and Metastasis of Hepatocellular Carcinoma-Progress and Prospect

Translational research on drug development and biomarker discovery for hepatocellular carcinoma

The advanced development of molecular targeted therapy for hepatocellular carcinoma

Molecular Subtyping of Hepatocellular Carcinoma: A Step Toward Precision Medicine

New advances in the treatment of intermediate and advanced hepatocellular carcinoma

Tumor Treatment Based on Translational Medicine

Recent Advances in the Studies of Hepatocellular Carcinoma

Research Advances in Systemic Therapy for Hepatocellular Carcinoma in the Era of Precision Medicine

Research Advances in Molecular Classification for Precision Diagnosis and Treatment of Hepatocellular Carcinoma

Personal Opinion on Improving the Outcome of Treatment for Liver Cancer

Conversion Therapy of Hepatocellular Carcinoma: Some Pivotal Issues to Be Resolved

Thirty Years’ Studies on Surgery and Related Basic Research of Hepatocellular Carcinoma